Literature DB >> 2922889

Interactive computerized morphometric analysis for the differential diagnosis between dysplasia and well differentiated adenocarcinoma of the prostate.

F Aragona1, V Franco, V Rodolico, G Dardanoni, D Cabibi, D Melloni, C Pavone, G Campesi, M Pavone-Macaluso.   

Abstract

To distinguish prostatic dysplasia (or adenosis) from well differentiated adenocarcinoma on transrectal needle biopsy, a morphometric study was conducted on 20 cases of adenosis and 20 cases of well differentiated adenocarcinoma of the prostate. About 100 cells for each patient were analyzed by means of a computerized image analyzer, and mean nuclear diameter, mean nuclear area, mean form factor and number of cells in eight classes of nuclear diameter were studied. The best predictors of malignancy (evaluated by means of Receiver Operating Characteristics curves) were mean nuclear area greater than 28 mu2, presence of more than 5% of cells with nuclear diameter greater than 6.15 mu, and mean nuclear diameter greater than 5 mu. Using these diagnostic criteria the probability of malignancy for a positive specimen rises from 14% (pre-test) to 75% (post-test).

Entities:  

Mesh:

Year:  1989        PMID: 2922889     DOI: 10.1007/BF00261048

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  9 in total

1.  Management of occult prostatic carcinoma.

Authors:  R M NESBIT; W C BAUM
Journal:  J Urol       Date:  1951-05       Impact factor: 7.450

2.  Comparison of needle biopsy and transurethral resection biopsy in the diagnosis of carcinoma of the prostate.

Authors:  B N Purser; B C Robinson; F K Mostofi
Journal:  J Urol       Date:  1967-08       Impact factor: 7.450

3.  Evaluation of shape descriptors for the morphometric analysis of cell nuclei.

Authors:  R Gschwind; C B Umbricht; J Torhorst; M Oberholzer
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

4.  Probabilities of eventually developing and of dying of cancer (risk among persons previously undiagnosed with the cancer).

Authors:  H Seidman; E Silverberg; A Bodden
Journal:  CA Cancer J Clin       Date:  1978 Jan-Feb       Impact factor: 508.702

5.  Survival of patients with incidentally found microscopic cancer of the prostate: results of a clinical trial of conservative treatment.

Authors:  D P Byar
Journal:  J Urol       Date:  1972-12       Impact factor: 7.450

6.  Combined histologic grading of prostatic carcinoma.

Authors:  A Böcking; J Kiehn; M Heinzel-Wach
Journal:  Cancer       Date:  1982-07-15       Impact factor: 6.860

7.  Adenosis of the prostate: a dysplastic lesion that can be confused with prostate adenocarcinoma.

Authors:  P N Brawn
Journal:  Cancer       Date:  1982-02-15       Impact factor: 6.860

8.  A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness.

Authors:  D A Diamond; S J Berry; H J Jewett; J C Eggleston; D S Coffey
Journal:  J Urol       Date:  1982-10       Impact factor: 7.450

9.  Carcinoma and dysplastic lesions of the prostate. A histomorphological analysis of 50 total prostatectomies by step-section technique.

Authors:  H Kastendieck; E Altenähr; H Hüsselmann; M Bressel
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-12-20
  9 in total
  1 in total

1.  Prognostic factors in prostate cancer.

Authors:  A Buhmeida; S Pyrhönen; M Laato; Y Collan
Journal:  Diagn Pathol       Date:  2006-04-03       Impact factor: 2.644

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.